IL138692A0 - Treatment and prevention of vascular disease - Google Patents
Treatment and prevention of vascular diseaseInfo
- Publication number
- IL138692A0 IL138692A0 IL13869299A IL13869299A IL138692A0 IL 138692 A0 IL138692 A0 IL 138692A0 IL 13869299 A IL13869299 A IL 13869299A IL 13869299 A IL13869299 A IL 13869299A IL 138692 A0 IL138692 A0 IL 138692A0
- Authority
- IL
- Israel
- Prior art keywords
- prevention
- treatment
- vascular disease
- vascular
- disease
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7968198P | 1998-03-27 | 1998-03-27 | |
| PCT/US1999/006595 WO1999050296A1 (en) | 1998-03-27 | 1999-03-25 | Treatment and prevention of vascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL138692A0 true IL138692A0 (en) | 2001-10-31 |
Family
ID=22152123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13869299A IL138692A0 (en) | 1998-03-27 | 1999-03-25 | Treatment and prevention of vascular disease |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1066323A1 (en) |
| JP (1) | JP2002509711A (en) |
| AU (1) | AU3365299A (en) |
| CA (1) | CA2324476A1 (en) |
| HU (1) | HUP0101731A2 (en) |
| IL (1) | IL138692A0 (en) |
| WO (1) | WO1999050296A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566131B1 (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of Smad6 expression |
| WO2001011013A2 (en) * | 1999-08-04 | 2001-02-15 | Uab Research Foundation | The interaction of smad6 with hox proteins and uses thereof |
| US6159697A (en) * | 2000-01-19 | 2000-12-12 | Isis Pharmaceuticals, Inc. | Antisense modulation of Smad7 expression |
| ITRM20030149A1 (en) | 2003-04-02 | 2004-10-03 | Giuliani Spa | ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD |
| MXPA06011199A (en) | 2004-03-31 | 2007-04-16 | Genentech Inc | Humanized anti-tgf-beta antibodies. |
| US8597646B2 (en) | 2005-10-25 | 2013-12-03 | The Johns Hopkins University | Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders |
| US8454952B2 (en) | 2006-03-13 | 2013-06-04 | The Johns Hopkins University | Augmentation of endothelial thromboresistance |
| US9084746B2 (en) | 2010-09-22 | 2015-07-21 | The Regents Of The University Of Colorado, A Body Corporate | Therapeutic applications of SMAD7 |
| CA2823154A1 (en) | 2010-12-27 | 2012-07-05 | Lsip, Llc | Ips cells and method for generating same |
| KR101359886B1 (en) * | 2011-12-28 | 2014-02-12 | 성균관대학교산학협력단 | Composition for treating sepsis or septic shock comprising the Peptide originated from the Smad6 |
| EP3553169B1 (en) | 2011-12-28 | 2021-11-03 | Kyoto Prefectural Public University Corporation | Normalization of culture of corneal endothelial cells |
| US10456448B2 (en) | 2013-03-08 | 2019-10-29 | The Regents Of The University Of Colorado, A Body Corporate | PTD-SMAD7 therapeutics |
| RU2712967C2 (en) | 2013-10-31 | 2020-02-03 | Киото Прифекчурал Паблик Юниверсити Корпорэйшн | Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium |
| US10882903B2 (en) | 2015-05-18 | 2021-01-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating an alphavirus infection |
| CN114457038B (en) * | 2021-11-08 | 2025-06-13 | 上海市第六人民医院 | Gene-carrying exosomes and preparation method and application thereof |
-
1999
- 1999-03-25 WO PCT/US1999/006595 patent/WO1999050296A1/en not_active Ceased
- 1999-03-25 CA CA002324476A patent/CA2324476A1/en not_active Abandoned
- 1999-03-25 JP JP2000541198A patent/JP2002509711A/en not_active Withdrawn
- 1999-03-25 IL IL13869299A patent/IL138692A0/en unknown
- 1999-03-25 HU HU0101731A patent/HUP0101731A2/en unknown
- 1999-03-25 AU AU33652/99A patent/AU3365299A/en not_active Abandoned
- 1999-03-25 EP EP99915041A patent/EP1066323A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002509711A (en) | 2002-04-02 |
| CA2324476A1 (en) | 1999-10-07 |
| WO1999050296A1 (en) | 1999-10-07 |
| HUP0101731A2 (en) | 2001-09-28 |
| EP1066323A1 (en) | 2001-01-10 |
| AU3365299A (en) | 1999-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100627A3 (en) | Prevention and treatment of amyloidogenic disease | |
| GB2368794B (en) | Prevention and treatment of amyloidogenic disease | |
| HUP0201205A2 (en) | Prevention and treatment of amyloidogenic disease | |
| GB9903841D0 (en) | Diagnosis and treatment of cancer | |
| EP1021177A4 (en) | Compositions and methods for prevention and treatment of vascular degenerative diseases | |
| AU2002367535A8 (en) | Diagnosis and treatment of vascular disease | |
| EP1119255A4 (en) | Novel compositions and methods for prevention and treatment of protozoal disease | |
| IL138692A0 (en) | Treatment and prevention of vascular disease | |
| IL141211A0 (en) | Prevention and treatment of viral disease | |
| AU6435398A (en) | Prevention and treatment of hepatocellular cancer | |
| GB9811598D0 (en) | Diagnosis and treatment of cancer | |
| GB9611180D0 (en) | Treatment of vascular lesions | |
| GB9911772D0 (en) | Diagnosis and treatment of atherosclerosis | |
| HUP0201966A3 (en) | Methods of treatment and drug screening methods | |
| EP1107778A4 (en) | Treatment of disease states | |
| GB9908059D0 (en) | Diagnosis and treatment of diseases | |
| AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| GB9516572D0 (en) | Prevention and/or treatment of disease | |
| AU2899099A (en) | Composition for treatment and prevention of coronary artery disease | |
| ZA9810932B (en) | Prevention of and treatment of amyloidogenic disease. | |
| GB0030866D0 (en) | Treatment and prevention of disease | |
| GB0030865D0 (en) | Treatment and prevention of disease | |
| GB0016197D0 (en) | Treatment and prevention of disease | |
| AU2003203740A1 (en) | Prevention and treatment of amyloidogenic disease | |
| GB9726745D0 (en) | Treatment of medical conditions |